Constitutively upregulated BCR-ABL1 fusion tyrosine kinase (TK) activity in chronic myeloid leukemia (CML) initiates complex signaling that dysregulates and transforms hematopoietic stem cells into CML (leukemia) stem cells or LSC. This evidence concerns the gene TKT and chronic myelogenous leukemia, BCR-ABL1 positive.